At present, the company has a total of 113 drug approval numbers, 31 active pharmaceutical ingredients, and 82 formulations: injections (a total of 57 numbers) and oral solid preparations (a total of 25 numbers). A total of 43 quality standards have been approved: 22 for active pharmaceutical ingredients and 21 for formulations. There are 9 raw materials for various new drug approval projects, 9 varieties of formulations, and 10 document numbers. The company has obtained a total of 50 domestic and foreign invention patent authorizations, including 9 foreign patents.